NWNing Wu

Ning Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ning Wu has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dissecting Immune Cell Ferroptosis via Single‐Cell Multi‐Omics Identifies RPL8 as a Potential Therapeutic Target for Depression

    by Guangpeng Zhang, Rundong He, Bijun Du, Yue Wu, Fuyuan Deng, Guangting Zhang, Jialu Yu, Tian Lin, Jianfei Sun, Ning Wu

    Depression is a major global health burden with limited treatment efficacy. Ferroptosis, an iron‐dependent form of regulated cell death, is implicated in its pathogenesis, but causal genetic links and cell‐type‐specific mechanisms remain unclear. We employed a multi‐omics framework integrating two‐sample Mendelian randomization (MR) using blood cis‐eQTLs (eQTLGen/GTEx) and depression (FinnGen), single‐cell eQTL (sceQTL) mapping in peripheral immune cells (OneK1K cohort), bioinformatic analyses, and in silico molecular docking. MR identified 42 ferroptosis genes associated with depression. Replication across cohorts pinpointed ribosomal protein RPL8 as a key protective factor ( β = −0.02 to −0.06, P FDR < 0.05). RPL8 expression was enriched in blood/immune cells. sceQTL analysis revealed its protective effect was mediated through 11 immune cell subtypes (e.g., CD4+/CD8+ T, B, NK cells; β range: −0.016 to −0.040, P FDR < 0.05). Molecular docking predicted high‐affinity binding between RPL8 and the ferroptosis execution ligand Ncoa4‐9A (ΔG = −9.3 kcal/mol). PheWAS indicated a favorable safety profile for RPL8 modulation. This study presents genetic evidence suggesting a potential causal link between ferroptosis and depression, and identifies RPL8 as a potential immune cell‐mediated protective factor. Based on these findings, we propose the “immune‐ribosome‐ferroptosis” axis as a promising direction for future therapeutic exploration.


  • Sidaxue ameliorates rheumatoid arthritis by inhibiting synovial neutrophil migration: Insights from an integrated multi-omics analysis

    by Bingyang Xu, Shuhan Liu, Mingxie Chen, Xinyue Li, Xuan Bi, Xiangqian Xue, Peijun Cheng, Xiaona Guo, Leilei Liu, Yingting Yang, et al.


  • Open Access

    Mechanisms of gypenosides in type 2 diabetes mellitus via regulation of m6A methylase METTL3/14 and demethylase FTO.

    by Jiayi Li, Shaoqian Zhang, Renwei Tian, Hebei Tai, Yating Zhang, Mingyi Hu, Guangbin Gong, Jianfei Sun, Ning Wu

    Type 2 diabetes mellitus (T2DM) is characterized by insufficient insulin secretion and insulin resistance. Gypenosides (GPs) are the major bioactive saponins extracted from Gynostemma pentaphyllum. Previous studies suggest that GPs have beneficial effects on T2DM, but the underlying mechanisms remain unclear. This study aims to investigate whether GPs exert therapeutic effects by influencing RNA N6-methyladenosine (m6A) methylation modification, thereby regulating the downstream phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Expression levels and methylation changes of METTL3, METTL14, and FTO in T2DM were analyzed using public databases, and related pathways were explored via gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The main active components of GPs were screened from pharmacological databases, followed by compound-target network construction, enrichment analyses, and prediction of potential targets and pathways. A T2DM model was induced in Sprague-Dawley rats using a high-fat/high-sugar diet combined with low-dose streptozotocin. Rats were randomly divided into 4 groups: GPs-treated group (GPG, 400 mg/kg), positive control group (PCG, metformin 100 mg/kg), normal saline control group (CONTROL), and T2DM model group (MODEL). Fasting blood glucose (FBG), oral glucose tolerance test (OGTT)-area under the glucose curve from 0 to 120 min (AUC0-120), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), serum inflammatory factors, and tissue pathology of pancreas and liver hematoxylin and eosin (HE) staining were assessed. Real-time fluorescence quantitative PCR and Western blotting were used to detect RNA and protein expression levels of METTL3, METTL14, FTO, PI3K, and AKT in pancreatic tissues. Molecular docking was applied to evaluate interactions between GPs' main components and METTL3, METTL14, and FTO to infer potential binding modes. Bioinformatic analyses showed downregulation of METTL3/14 and upregulation of FTO in T2DM samples (all PPMETTL3/14 mRNA and protein levels, and down-regulated FTO mRNA/protein levels in pancreatic tissue (all PPMETTL3/14 up-regulation and FTO down-regulation, leading to enhanced m6A methylation and subsequent activation of the PI3K/AKT signaling pathway. These findings provide strong evidence for GPs regulation of epigenetic m6A RNA modification and insulin-related downstream pathways, and suggest that natural compounds targeting m6A regulation may be explored in the future for metabolic disease interventions.

  • Tanshinone IIA ameliorates pancreatic injury in type 2 diabetic mice by modulating inflammation and endoplasmic reticulum stress via the IL-6/JAK2/STAT3 pathway

    by Yingfeng Li, Desheng Wang, Yuhang Liu, Chenyang Liu, Meixi Chen, Jingqi Li, Zunqiu Wu, Ning Wu

    Type 2 diabetes mellitus (T2DM) is a severe metabolic disorder in which pancreatic injury plays a pivotal role in disease progression. Tanshinone IIA (TanIIA), a bioactive compound extracted from Salvia miltiorrhiza, has shown therapeutic potential in diabetes management. However, its protective effects on pancreatic injury and underlying pharmacological mechanisms remain unclear. In this study, TanIIA significantly reduced fasting blood glucose, improved insulin resistance, and alleviated islet structural damage and β-cell apoptosis. Potential TanIIA targets were initially predicted through integrated network pharmacology, weighted gene co-expression network analysis (WGCNA), and differential gene expression analysis. Based on these integrated data, five machine learning algorithms were applied to identify candidate targets. PTGS2, NR4A2, MGLL, GABRA2, and IL-6 were determined to be core targets and were validated by qRT-PCR, with functional enrichment indicating that the JAK-STAT pathway is a key regulatory axis. Molecular docking revealed strong binding affinities between TanIIA and these core targets, with calculated binding energies of -8.7 (PTGS2), -7.6 (NR4A2), -9.8 (MGLL), -8.3 (GABRA2), and − 7.5 (IL-6) kcal/mol. Furthermore, molecular dynamics simulations confirmed the stable interaction between TanIIA and IL-6. In vivo experiments further demonstrated that TanIIA modulated the IL-6/JAK2/STAT3 pathway In vivo experiments further demonstrated that TanIIA modulated the IL-6/JAK2/STAT3 pathway, suppressed proinflammatory cytokines, promoted anti-inflammatory IL-10 expression, and regulated macrophage polarization, thereby improving the inflammatory microenvironment in islets. Additionally, TanIIA activated the PI3K-AKT pathway, alleviated glucolipotoxicity-induced endoplasmic reticulum (ER) stress, and downregulated ER stress-related proteins including p-IRE1α, GRP78, XBP1s, and CHOP, ultimately inhibiting β-cell apoptosis. Collectively, these findings suggest that TanIIA ameliorates pancreatic damage in T2DM mice by targeting inflammation and ER stress through IL-6/JAK2/STAT3 signaling, providing new mechanistic insights into its antidiabetic potential.


  • Tanshinone IIA suppresses endoplasmic reticulum stress-mediated IRE1α/TXNIP/NLRP3 pathway to mitigate pyroptosis in type 2 diabetic osteoporosis

    by Zhuojun Jiang, Jiancao Zuo, Hailan Luo, Yan Tang, Zhuoting Tan, Meining An, Yuxuan Feng, Shunxin Shi, Jianfei Sun, Ning Wu


  • Open Access

    Unraveling the Role of Microcystin-LR in Ferroptosis and Sepsis Pathogenesis: A Comprehensive Review

    by Honglian Ying, Hongli Zhao, Xiaqiu Zhang, Haoyuan Feng, Manjuan Zhou, Zunqiu Wu, Ning Wu

    Sepsis, a systemic inflammatory response syndrome triggered by infection, is characterized by acute onset, rapid progression, and high mortality. Ferroptosis, a form of programmed cell death induced by iron-dependent lipid peroxidation, is closely associated with the occurrence and development of various diseases. Microcystin-LR (MC-LR) can exacerbate sepsis by causing multi-organ damage via the ferroptosis pathway. Currently, the relationship between MC-LR, ferroptosis, and sepsis remains unclear. Understanding its pathogenesis and identifying potential therapeutic targets may reduce the mortality of sepsis patients and lead to clinical improvement. This article reviews the relationship among MC-LR, ferroptosis, and sepsis, focusing on the mechanism by which MC-LR exposure induces sepsis from the ferroptosis perspective, providing a theoretical basis for the prevention and treatment of MC-LR-exposure-induced sepsis in the population.


  • Open Access

    Targeting the chemokine-microglia nexus: A novel strategy for modulating neuroinflammation in Alzheimer's disease

    by Bingyang Xu, Chao Tang, Rongshou Han, Chaomin Zhu, Yuxuan Yang, Heyi Li, Ning Wu, Dian He

    An increasing body of evidence suggests neuroinflammation has a prominent role in the pathogenesis of Alzheimer's disease (AD). The amyloid-β-tau-neurodegeneration (ATN) classification system is now being expanded toward an amyloid-β-tau neurodegeneration-neuroinflammation (ATN(I)) system. Activated microglia and reactive astrocytes are the key hubs for neuroinflammation in AD, and chemokines are recognized as pivotal modulators of microglial innate immune functions. In this review, based on the chemokine-microglia regulatory axis, we elucidate the mechanisms through which chemokines influence microglial function, potentially modulating neurotoxicity or neuroprotection in AD. The key chemokines that significantly affect microglial polarization, such as CCL2, CCL3, and CXCL1, are summarized, and their role in disease progression are elaborated. Additionally, we explore prospective therapeutic interventions centered on the chemokine-microglia regulatory axis, offering valuable perspectives on pathobiology of AD and avenues for pharmacological advancements.


  • Comprehensive analysis of the Global Burden and epidemiological trends of meningitis from 1990 to 2021

    by Chao Tang, Rongshou Han, Jiaxin Yang, Ning Wu, Dian He

    Background Despite significant advances in prevention and treatment strategies, meningitis continues to pose a substantial global health challenge. The disease burden demonstrates marked geographical disparities, with disproportionate impact in resource-limited settings, particularly within the “meningitis belt” of Sub-Saharan Africa. The global meningitis burden is influenced by a complex interplay of environmental, behavioral, and socioeconomic determinants. Methods Leveraging the Global Burden of Disease (GBD) 2021 database, we conducted a comprehensive analysis of global meningitis burden from 1990 to 2021. The study employed DisMod-MR 2.1, an advanced Bayesian meta-regression tool, for epidemiological modeling. We implemented age-period-cohort analysis to evaluate mortality trends and utilized the Comparative Risk Assessment framework to assess risk factors. The relationship between socio-demographic index (SDI) and disease burden was examined through Spearman’s rank correlation analysis. Results Our analysis revealed significant geographical and pathogen-specific variations in disease burden. Globally, the age-standardized incidence rate stands at 31.65 per 100,000 with a corresponding mortality rate of 2.95 per 100,000. The disease burden demonstrates a striking gradient across SDI levels, with low SDI regions experiencing the highest burden, approximately 17 times higher than high SDI regions. Neonatal mortality rates remain particularly concerning at 129.69 per 100,000, while under-5 mortality rates stand at 34.50 per 100,000. The Eastern Sub-Saharan African region emerges as an area of particular concern, with disease burden significantly exceeding global averages. Behavioral risks, child and maternal malnutrition, and low birth weight/short gestation emerged as the primary risk factors, each contributing to 0.15 million deaths and 13.41 million DALYs. Strong negative correlations were observed between all risk factors and SDI values (correlation coefficients ranging from − 0.55 to -0.75), indicating higher disease burden in regions with lower socio-demographic development. Conclusion While substantial progress has been achieved in global meningitis control, particularly in reducing under-5 mortality rates, significant disparities persist between high and low SDI regions. Our findings emphasize the critical need for targeted interventions in resource-limited settings and continued surveillance efforts to address remaining challenges in meningitis control.


  • JAK1, SKI, ZBTB16 as potential biomarkers mediate the inflammatory response in keratoconjunctivitis sicca

    by Zijian Dong, Chen Wang, Shannan Dou, Xinyi Yang, Desheng Wang, Kaixi Shi, Ning Wu